144 related articles for article (PubMed ID: 27208691)
21. Posttransplant Kaposi sarcoma: Analysis of a series of 13 patients.
González-Cruz C; Ferrándiz-Pulido C; Ferrer Fàbregas B; García-Patos Briones V
Med Clin (Barc); 2021 Oct; 157(7):339-343. PubMed ID: 34246484
[TBL] [Abstract][Full Text] [Related]
22. Kaposi's sarcoma associated with previous human herpesvirus 8 infection in kidney transplant recipients.
Cattani P; Capuano M; Graffeo R; Ricci R; Cerimele F; Cerimele D; Nanni G; Fadda G
J Clin Microbiol; 2001 Feb; 39(2):506-8. PubMed ID: 11158097
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of post-transplant Kaposi's sarcoma by reduction of immunosuppression.
Duman S; Töz H; Aşçi G; Alper S; Ozkahya M; Unal I; Celik A; Ok E; Başçi A
Nephrol Dial Transplant; 2002 May; 17(5):892-6. PubMed ID: 11981080
[TBL] [Abstract][Full Text] [Related]
24. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.
Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S
Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770
[TBL] [Abstract][Full Text] [Related]
25. Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy.
Pantuck AJ; Seligson DB; Klatte T; Yu H; Leppert JT; Moore L; O'Toole T; Gibbons J; Belldegrun AS; Figlin RA
Cancer; 2007 Jun; 109(11):2257-67. PubMed ID: 17440983
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of conversion to sirolimus in posttransplantation Kaposi's sarcoma.
Gutiérrez-Dalmau A; Sánchez-Fructuoso A; Sanz-Guajardo A; Mazuecos A; Franco A; Rial MC; Iranzo P; Torregrosa JV; Oppenheimer F; Campistol JM
Transplant Proc; 2005 Nov; 37(9):3836-8. PubMed ID: 16386556
[TBL] [Abstract][Full Text] [Related]
27. Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitors.
Campistol JM; Schena FP
Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i17-22. PubMed ID: 17456614
[TBL] [Abstract][Full Text] [Related]
28. Herpesvirus-like DNA sequences and Kaposi's sarcoma: relationship with epidemiology, clinical spectrum, and histologic features.
Noel JC; Hermans P; Andre J; Fayt I; Simonart Th; Verhest A; Haot J; Burny A
Cancer; 1996 May; 77(10):2132-6. PubMed ID: 8640682
[TBL] [Abstract][Full Text] [Related]
29. The interleukin-6-174 promoter polymorphism is associated with a risk of development of Kaposi's sarcoma in renal transplant recipients.
Gazouli M; Zavos G; Papaconstantinou I; Lukas JC; Zografidis A; Boletis J; Kostakis A
Anticancer Res; 2004; 24(2C):1311-4. PubMed ID: 15154666
[TBL] [Abstract][Full Text] [Related]
30. Visceral Kaposi's sarcoma associated with human herpesvirus 8 seroconversion in a heart transplant recipient.
Collart F; Kerbaul F; Damaj G; Zandotti C; Vey N; Mesana T; Mouly-Bandini A
Transplant Proc; 2004 Dec; 36(10):3173-4. PubMed ID: 15686722
[TBL] [Abstract][Full Text] [Related]
31. Clinical features and course of Kaposi's sarcoma in kidney transplant patients: report of 13 cases.
Montagnino G; Bencini PL; Tarantino A; Caputo R; Ponticelli C
Am J Nephrol; 1994; 14(2):121-6. PubMed ID: 8080004
[TBL] [Abstract][Full Text] [Related]
32. Reccurence of Kaposi's sarcoma after increased exposure to sirolimus.
Boratyńska M; Zmonarski SC; Klinger M
Int Immunopharmacol; 2006 Dec; 6(13-14):2018-22. PubMed ID: 17161356
[TBL] [Abstract][Full Text] [Related]
33. Posttransplant Kaposi's sarcoma: report from a single center.
Huang JY; Chiang YJ; Lai PC; Shih LY; Huang CC; Chu SH; Wu CH
Transplant Proc; 2004 Sep; 36(7):2145-7. PubMed ID: 15518778
[TBL] [Abstract][Full Text] [Related]
34. Development of Kaposi's sarcoma under sirolimus-based immunosuppression and successful treatment with imiquimod.
Babel N; Eibl N; Ulrich C; Bold G; Sefrin A; Hammer MH; Rosenberger C; Reinke P
Transpl Infect Dis; 2008 Feb; 10(1):59-62. PubMed ID: 17428275
[TBL] [Abstract][Full Text] [Related]
35. Human herpesvirus type 8 genotypes in iatrogenic, classic and AIDS-associated Kaposi's sarcoma from Greece.
Gazouli M; Papaconstantinou I; Zavos G; Metaxa-Mariatou V; Nasioulas G; Boletis J; Arapadoni-Dadioti P; Giaslakiotis K; Zografidis A; Kostakis A
Anticancer Res; 2004; 24(3a):1597-602. PubMed ID: 15274328
[TBL] [Abstract][Full Text] [Related]
36. Tonsillar Kaposi sarcoma in a renal transplant patient.
Howard JH; Darrow M; Chen LX; Alnimri M; Jen KY
Transpl Infect Dis; 2020 Oct; 22(5):e13347. PubMed ID: 32495980
[TBL] [Abstract][Full Text] [Related]
37. Detection of herpesvirus-like sequences in Kaposi's sarcoma from heart transplant recipients.
Briz M; Alonso-Pulpon L; Crespo-Leiro MG; Exposito C; Almagro M; Busto MJ; Fernández MN
J Heart Lung Transplant; 1998 Mar; 17(3):288-93. PubMed ID: 9563605
[TBL] [Abstract][Full Text] [Related]
38. Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients.
Regamey N; Tamm M; Wernli M; Witschi A; Thiel G; Cathomas G; Erb P
N Engl J Med; 1998 Nov; 339(19):1358-63. PubMed ID: 9801396
[TBL] [Abstract][Full Text] [Related]
39. Detection of human herpesvirus 8 and human T-cell lymphotropic virus type 1 sequences in Kaposi sarcoma.
Lebbé C; Agbalika F; de Crémoux P; Deplanche M; Rybojad M; Masgrau E; Morel P; Calvo F
Arch Dermatol; 1997 Jan; 133(1):25-30. PubMed ID: 9006369
[TBL] [Abstract][Full Text] [Related]
40. Monitoring antitumor efficacy of rapamycin in Kaposi sarcoma.
Di Paolo S; Teutonico A; Ranieri E; Gesualdo L; Schena PF
Am J Kidney Dis; 2007 Mar; 49(3):462-70. PubMed ID: 17336708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
